Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (γ)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational study

被引:1
|
作者
Tang, Shi-Chuan [1 ,2 ,3 ]
Wu, Ye-Ye [4 ]
Lin, Zhi-Wen [3 ]
Chen, Qing-Jing [1 ,2 ,3 ]
Luo, Cong [5 ]
Li, Yun-Tong [6 ]
Fu, Jun [3 ]
Zheng, Li-Fang [3 ]
You, Peng-Hui [7 ]
You, Song [3 ]
You, Wu-Yi [8 ]
Lin, Ke-Can [3 ]
Zhou, Wei-Ping [9 ]
Lin, Kong-Ying [1 ,2 ,3 ]
Zeng, Yong-Yi [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Med Coll, Clin 1, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[3] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[4] Second Mil Med Univ, Navy Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surgery2, Shanghai, Peoples R China
[5] Peoples Hosp Zizhong Cty, Dept Hepatopancreatobiliary Surg, Zizhong, Peoples R China
[6] Xiamen Univ, Dept Hepatobiliary Surg, ZhongShan Hosp, Xiamen, Peoples R China
[7] Fujian Med Univ, Bioinformat Sample Bank, Biobank Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[8] Fujian Med Univ, Dept Radiat, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[9] Navy Med Univ, Mil Med Univ 2, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; alpha-fetoprotein; des-gamma (gamma)-carboxy prothrombin; resection; prognosis; CARBOXY PROTHROMBIN; LIVER-TRANSPLANTATION; TUMOR-MARKERS; DIAGNOSIS; RECURRENCE; SURVIVAL; ABLATION; MODEL;
D O I
10.3389/fonc.2024.1425292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The utility of pre- and post-operative alpha-fetoprotein (AFP) and des-gamma (gamma)-carboxy prothrombin (DCP) expression patterns and their dynamic changes as predictors of the outcome of hepatic resection for hepatocellular carcinoma (HCC) has yet to be well elucidated. Methods: From a multicenter database, AFP and DCP data during the week prior to surgery and the first post-discharge outpatient visit (within 1-2 months after surgery) were collected from patients with HCC who underwent hepatectomy. AFP-DCP expression patterns were categorized according to the number of positive tumor markers (AFP >= 20ng/mL, DCP >= 40mAU/mL), including double-negative, single-positive, and double-positive. Changes in the AFP-DCP expression patterns were delineated based on variations in the number of positive tumor markers when comparing pre- and post-operative patterns. Results: Preoperatively, 53 patients (8.3%), 337 patients (52.8%), and 248 patients (38.9%) exhibited double-negative, single-positive, and double-positive AFP-DCP expression patterns, respectively. Postoperatively, 463 patients (72.6%), 130 patients (20.4%), and 45 patients (7.0%) showed double-negative, single-positive, and double-positive AFP-DCP expression patterns, respectively. Survival analysis showed a progressive decrease in recurrence-free (RFS) and overall survival (OS) as the number of postoperative positive tumor markers increased (both P < 0.001). Multivariate analysis showed that postoperative AFP-DCP expression pattern, but not preoperative AFP-DCP expression pattern, was an independent risk factor for RFS and OS. Further analysis showed that for patients with positive preoperative markers, prognosis gradually improves as positive markers decrease postoperatively. In particular, when all postoperative markers turned negative, the prognosis was consistent with that of preoperative double-negative patients, regardless of the initial number of positive markers. Conclusions: AFP-DCP expression patterns, particularly postoperative patterns, serve as vital sources of information for prognostic evaluation following hepatectomy for HCC. Moreover, changes in AFP-DCP expression patterns from pre- to post-operation enable dynamic prognostic risk stratification postoperatively, aiding the development of individualized follow-up strategies.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma
    Kuzuya, Teiji
    Kawabe, Naoto
    Muto, Hisanori
    Wada, Yuryo
    Komura, Gakushi
    Nakano, Takuji
    Tanaka, Hiroyuki
    Nakaoka, Kazunori
    Ohno, Eizaburo
    Funasaka, Kohei
    Nagasaka, Mitsuo
    Miyahara, Ryoji
    Hirooka, Yoshiki
    CURRENT ONCOLOGY, 2024, 31 (08) : 4225 - 4240
  • [32] Half-Life of Serum Alpha-Fetoprotein An Early Prognostic Index of Recurrence and Survival After Hepatic Resection for Hepatocellular Carcinoma
    Shim, Ju Hyun
    Han, Seungbong
    Lee, Young-Joo
    Lee, Sung-Gyu
    Kim, Kang Mo
    Lim, Young-Suk
    Chung, Young-Hwa
    Lee, Yung Sang
    Lee, Han Chu
    ANNALS OF SURGERY, 2013, 257 (04) : 708 - 717
  • [33] Rapid and early alpha-fetoprotein and des-gamma-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma
    Oyama, Kenji
    Koda, Masahiko
    Sugihara, Takaaki
    Kishina, Manabu
    Miyoshi, Kenichi
    Okamoto, Toshiaki
    Hodotsuka, Masanori
    Fujise, Yuki
    Matono, Tomomitsu
    Tokunaga, Shiho
    Okamoto, Kinya
    Hosho, Keiko
    Okano, Junichi
    Murawaki, Yoshikazu
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 655 - 662
  • [34] Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma
    Chon, Young Eun
    Choi, Gi Hong
    Lee, Myoung Ha
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Kyung Sik
    Choi, Jin Sub
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (10) : 2332 - 2341
  • [35] The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma
    Okamura, Yukiyasu
    Sugiura, Teiichi
    Ito, Takaaki
    Yamamoto, Yusuke
    Ashida, Ryo
    Uesaka, Katsuhiko
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S921 - S928
  • [36] SIGNIFICANCE OF SERUM ALPHA-FETOPROTEIN (AFP) AND DES-GAMMA-CARBOXY PROTHROMBIN (DCP) LEVELS TO IDENTIFY TREATMENT FAILURE AND CONTRAINDICATION FOR HEPATECTOMY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Yamamoto, Kentaroh
    Imamura, Hiroshi
    Aoki, Taku
    Beck, Yoshifumi
    Hasegawa, Kiyoshi
    Sugawara, Yasuhiko
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    HEPATOLOGY, 2010, 52 (04) : 1192A - 1192A
  • [37] The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma
    Yukiyasu Okamura
    Teiichi Sugiura
    Takaaki Ito
    Yusuke Yamamoto
    Ryo Ashida
    Katsuhiko Uesaka
    Annals of Surgical Oncology, 2016, 23 : 921 - 928
  • [38] DETERMINATION OF OPTIMUM CUTOFF LEVELS OF PLASMA DES-GAMMA-CARBOXY PROTHROMBIN AND SERUM ALPHA-FETOPROTEIN FOR THE DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA USING RECEIVER OPERATING CHARACTERISTIC CURVES
    FUJIYAMA, S
    IZUNO, K
    YAMASAKI, K
    SATO, T
    TAKETA, K
    TUMOR BIOLOGY, 1992, 13 (5-6) : 316 - 323
  • [39] Treatment Response Evaluated By Des-Gamma-Carboxy Prothrombin and Alpha-Fetoprotein L3 Fraction Can Predict Prognosis of Hepatocellular Carcinoma Independently of Radiological Evaluation
    Imamura, Jun
    Tateishi, Ryosuke
    Obi, Shuntaro
    Shiina, Shuichiro
    Sato, Shinpei
    Ohki, Takamasa
    Masuzaki, Ryoto
    Goto, Tadashi
    Goto, Eriko
    Sato, Takahisa
    Enooku, Kenichiro
    Yoshida, Haruhiko
    Kawabe, Takao
    Omata, Masao
    GASTROENTEROLOGY, 2009, 136 (05) : A862 - A862
  • [40] Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study
    Lin, Kong-Ying
    Zhang, Jian-Xi
    Lin, Zhi-Wen
    Chen, Qing-Jing
    Luo, Liu-Ping
    Chen, Jin-Hong
    Wang, Kui
    Tai, Sheng
    Zhang, Zhi-Bo
    Wang, Shi-Feng
    Li, Jing-Dong
    Wang, Kai
    Zheng, Lu
    Zheng, Si-Ming
    Wu, Meng-Meng
    Lin, Ke-Can
    Yang, Tian
    Zeng, Yong-Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15